Evidence map›Paper›PMID 40632771›Full record

ArticleACS infectious diseases2025

Membrane Expression Enhances Folding, Multimeric Structure Formation, and Immunogenicity of Viral Capsid Proteins.

Junru Cui, Fangfeng Yuan, Jane Qin, Ju Hyeong Jeon, Dong Soo Yun, Tianlei Wang, Renhuan Xu, Hong Cao, Ashleigh A Tungate, Christopher L Netherton and 1 more

Abstract read
In one paragraph

Article in ACS infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Junru CuiKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.ORCID 0000-0001-5872-2194
Fangfeng YuanKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.ORCID 0000-0001-9310-0382
Jane QinAdvanced RNA Vaccine Technologies, Inc., North Bethesda, Rockville, Maryland 20852, United States.
Ju Hyeong JeonAdvanced RNA Vaccine Technologies, Inc., North Bethesda, Rockville, Maryland 20852, United States.
Dong Soo YunKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Tianlei WangKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Renhuan XuAdvanced RNA Vaccine Technologies, Inc., North Bethesda, Rockville, Maryland 20852, United States.
Hong CaoInnovHope, Inc., Framingham, Massachusetts 01701, United States.
Ashleigh A TungateThe Pirbright Institute, Surrey GU24 0NF, U.K.
Christopher L NethertonThe Pirbright Institute, Surrey GU24 0NF, U.K.ORCID 0000-0002-1286-8590
Jianzhu ChenKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Paula T Hammond · 1985 to 2026
$93.9M
NCI NIH HHS P30 CA014051
6 · The paper itself

Abstract

Viral capsid proteins are widely explored for subunit vaccine development but are often hampered by their complexity of production and low immunogenicity. Here, we report a simple approach to overcoming these challenges by combining mRNA vaccine technology with protein engineering. Using African swine fever virus (ASFV) capsid proteins P72 and penton as models, we engineered them into membrane-bound and secreted forms and compared their immunogenicity to that of the native intracellular form in mice and pigs through mRNA vaccination. The membrane-bound and secreted P72 and penton folded into their native multimeric structure independent of the viral chaperone, therefore preserving their conformational epitopes. The membrane-bound P72 and penton also elicited significantly stronger antibody and T cell responses than their secreted or intracellular counterparts. Our study provides a simple approach to enhancing folding, multimeric structure formation, and immunogenicity of viral capsid proteins for ASFV subunit vaccine development and immunogenicity of intracellular proteins in general.

Indexed as

African Swine Fever VirusCapsid ProteinsImmunogenicity, VaccineViral VaccinesAnimalsAntibodies, ViralFemaleMiceMice, Inbred BALB CProtein EngineeringProtein FoldingSwineVaccines, SubunitAntibodies, ViralCapsid ProteinsVaccines, SubunitViral Vaccinesantigen engineeringASFVimmunogenicitymRNA vaccineviral capsid protein

Identifiers

PMID40632771
PMCPMC12341548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.